Abstract
Photoaging is a chronic and multifactorial form of skin aging primarily induced by ultraviolet (UV) radiation. It is characterized by oxidative stress, DNA damage, chronic inflammation, pigmentary alterations, and extracellular matrix (ECM) degradation, which ultimately lead to wrinkle formation, loss of elasticity, and uneven pigmentation. Exosomes, nanosized extracellular vesicles that mediate intercellular communication, have attracted growing attention in photoaging research. Emerging evidence suggests that exosomes may both contribute to photoaging and promote tissue repair by modulating cellular responses. However, despite the growing body of evidence, the field still lacks an integrated review that links exosome biogenesis and functional properties to the mechanisms of photoaging, their therapeutic potential, and the major translational barriers to clinical application. Therefore, this review aims to systematically summarize the biogenesis and biological properties of exosomes, clarify their mechanistic roles in photoaging, particularly in the regulation of oxidative stress, and evaluate their potential as therapeutic agents and delivery platforms for anti-photoaging and regenerative medicine. It further examines the effects of native exosomes derived from multiple cell sources, with a focus on stem cells, keratinocytes, and melanocytes. Finally, it outlines translational opportunities for exosome-based interventions in anti-photoaging and regenerative medicine, including engineered exosome mimetics and other nanomedicine-based strategies. It also highlights the key knowledge gaps and technical challenges that must be addressed to facilitate clinical translation. In conclusion, exosomes represent a promising yet still evolving strategy for the prevention and treatment of photoaging because of their dual roles in intercellular signaling and tissue regeneration. Nevertheless, further standardization of isolation, characterization, engineering, safety assessment, and regulatory evaluation is essential before their full clinical potential can be realized.